Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2010
11/18/2010US20100291245 Soft, chewable and orally dissolvable and/or disintegrable products
11/18/2010US20100291240 Method to Stabilize a Dietary Supplement to Facilitate Joint Health in Humans
11/18/2010US20100291238 Appetite suppressant product and method
11/18/2010US20100291228 Scavenger of in vivo harmful reactive oxygen species and/or free radicals
11/18/2010US20100291217 Pharmaceutical compositions
11/18/2010US20100291216 Pharmaceutical compositions
11/18/2010US20100291207 Pharmaceutical formulation comprising ezetimibe
11/18/2010US20100291191 Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
11/18/2010US20100291189 Method for producing a membrane protein
11/18/2010US20100291170 Novel therapies for chronic renal failure
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291076 Antibodies specific for dkk-1 and their uses
11/18/2010US20100291075 Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies
11/18/2010US20100291057 Composition for Reducing Oxidative Stress and/or Side Effects Occurring During Cancer Chemotherapy or Improving Nutritional Status During Cancer Chemotherapy
11/18/2010US20100291056 Pharmaceutical Compositions Comprising Prasugrel and Cyclodextrin Derivatives and Methods of Making and Using the Same
11/18/2010US20100291033 Albumin Fusion Proteins
11/18/2010US20100291027 Hyaluronic acid (ha) injection vehicle
11/18/2010US20100291020 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
11/18/2010US20100290995 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010US20100290987 Methods and compositions for detecting and modulating o-glycosylation
11/18/2010DE102009022046A1 Entfärbte Extrakte der Pflanze Pandanus conoideus Discolored extracts of the plant Pandanus conoideus
11/18/2010CA2763336A1 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
11/18/2010CA2762107A1 Sublingual dexmedetomidine compositions and methods of use thereof
11/18/2010CA2761932A1 L-arabinose plus chromium for controlling the metabolization of sucrose
11/18/2010CA2761901A1 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
11/18/2010CA2761853A1 Benzoxazolone derivatives as aldosterone synthase inhibitors
11/18/2010CA2760340A1 Azacyclic spiroderivatives as hsl inhibitors
11/18/2010CA2760179A1 Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound
11/18/2010CA2759196A1 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
11/18/2010CA2759077A1 Sitagliptin synthesis
11/18/2010CA2758202A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/17/2010EP2251339A2 Compounds
11/17/2010EP2251338A2 Organic compounds
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2251023A1 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent
11/17/2010EP2251015A1 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
11/17/2010EP2251006A1 Microparticles and pharmaceutical compositions thereof
11/17/2010EP2250911A1 Weight-loss supplement
11/17/2010EP2250157A1 Novel heterocyclic compounds
11/17/2010EP2250156A1 Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/17/2010EP2249819A1 Phytol as a cholesterol lowering agent
11/17/2010EP2249666A1 Protein-dense micellar casein-based liquid enteral nutritional composition
11/17/2010EP2173711B1 Phenoxy-pyrrolidine derivative and its use and compositions
11/17/2010EP2097411B1 3 -amino-imidazo [1,2 -a]pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes
11/17/2010EP2021339B1 Rosiglitazone hydrochloride hemihydrate
11/17/2010EP1934175B1 Anti-hypercholesterolemic compounds
11/17/2010EP1910400B1 Improved crystalline form of the compound a-348441
11/17/2010EP1435794B1 Pet food composition for regulating body weight and preventing obesity and related disorders in pets
11/17/2010CN101888877A Pyridine derivatives for the treatment of amyloid-related diseases
11/17/2010CN101888850A Peptide compounds for treating obesity and insulin resistance
11/17/2010CN101888844A Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs
11/17/2010CN101885784A Method for producing glucomannan by liquid culture of konjac cells
11/17/2010CN101885728A Inhibitor of dipeptidyl peptidase IV and application thereof in preventing and treating diabetes
11/17/2010CN101884789A Ctgf as target for the therapy of diabetic nephropathy
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/17/2010CN101884767A Plant extract composite for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884766A Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884765A Medicament for treating big belly known as beer belly
11/17/2010CN101884760A Chinese medicinal composition for treating diabetes mellitus and preparation method thereof
11/17/2010CN101884739A Food therapy preparation for preventing and treating diabetes based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884735A Medicament for treating dyslipidemia and preparation method thereof
11/17/2010CN101884733A Weight reducing tea
11/17/2010CN101884723A Anemarrhena and goldthread composition preparation used for treating diabetes and preparation method thereof
11/17/2010CN101884700A Tea-containing Chinese medicinal composition
11/17/2010CN101884694A Traditional Chinese medicine for treating diabetic foot
11/17/2010CN101884693A Traditional Chinese medicine for treating diabetic eye diseases
11/17/2010CN101884678A Pure Chinese medicinal composition for treating metabolic syndrome and pure Chinese medicinal preparation prepared from same
11/17/2010CN101884675A Food therapy preparation for preventing and treating hyperlipidemia based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884665A Traditional Chinese medicine extract with alpha-glucuroide and xanthine oxidase inhibiting effect and preparation method and usage thereof
11/17/2010CN101884661A Traditional Chinese medical preparation containing leeches and astragalus and used for treating cardiovascular and cerebrovascular diseases
11/17/2010CN101884637A Medicinal composition for treating cardiovascular diseases and application thereof
11/17/2010CN101884635A Amino acid hypoglycemic capsule
11/17/2010CN101884634A Composition for treating cardiovascular diseases
11/17/2010CN101884627A Pioglitazone hydrochloride gastric residential sustained release tablet and preparation method thereof
11/17/2010CN101884611A Method for preparing medicinal invert sugar by sugar hydrolysis
11/17/2010CN101884412A Method for preparing natural compound calcium amino acid chelate
11/17/2010CN101884398A Chromium-enriched wheat bran and preparation method thereof
11/17/2010CN101884280A Method for planting selenium-enriched food for preventing diseases and resisting cancer
11/17/2010CN101297863B Mulberry bark extract with glycosidase inhibiting function and preparation thereof
11/17/2010CN101224205B Composition of atorvastatin and levorotatory amlodipine and preparing method thereof
11/17/2010CN101129498B New use of tree peony oil in decreasing blood sugar and slimming
11/17/2010CN101129196B Health product with slimming function
11/17/2010CN101102783B Black soybean seedcoat extract and its extracting method and application
11/17/2010CN101073666B Method for producing kallidin proenzyme raw-material medicine
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
11/16/2010US7834030 PPAR agonists; modulate lipid and/or carbohydrate metabolism in mammals; prevention and/or treatment of type-2 diabetes, atherosclerosis, cardiovascular disorders; 3-(2-Chloro-4-{1-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethoxy}-phenyl)-4H-[1,2,4]oxadiazol-5-one
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010US7833982 Methods of treating dermal ulcers with thrombin derived peptides
11/16/2010US7833972 Proteins and use thereof
11/16/2010US7833553 Sulfur-containing proanthocyanidin oligomer compositon and process for producing the same
11/16/2010US7833542 Method and composition for the treatment of scars
11/16/2010US7833537 administering isolated and purified T. suis helminthic parasite preparation free of human bacterial, mycobacterial and viral pathogens; treating inflammatory bowel disease, crohn's disease, and ulcerative colitis, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 1298